167 related articles for article (PubMed ID: 6142847)
1. Beta-adrenergic receptor subtypes in iris-ciliary body of rabbits.
Schmitt CJ; Gross DM; Share NN
Graefes Arch Clin Exp Ophthalmol; 1984; 221(4):167-70. PubMed ID: 6142847
[TBL] [Abstract][Full Text] [Related]
2. In vitro determination of the ability of drugs to bind to adrenergic receptors.
Neufeld AH; Page ED
Invest Ophthalmol Vis Sci; 1977 Dec; 16(12):1118-24. PubMed ID: 200584
[TBL] [Abstract][Full Text] [Related]
3. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
5. Tracheal relaxing effects and beta 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues.
Kikkawa H; Naito K; Ikezawa K
Jpn J Pharmacol; 1991 Oct; 57(2):175-85. PubMed ID: 1687479
[TBL] [Abstract][Full Text] [Related]
6. Binding characteristics of 3H-dihydroalprenolol to beta-adrenoceptors of rat heart treated with neuraminidase.
Nagatomo T; Sasaki M; Tsuchihashi H; Imai S
Jpn J Pharmacol; 1983 Aug; 33(4):851-7. PubMed ID: 6314011
[TBL] [Abstract][Full Text] [Related]
7. Characterization of beta-adrenergic receptors in rat ovary.
Laszlovszky I; Erdö SL
Eur J Pharmacol; 1983 Dec; 96(1-2):101-4. PubMed ID: 6141056
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of beta 1- and beta 2-adrenoceptors in the rabbit heart: quantitative analysis of the regional distribution by (-)-3H-dihydroalprenolol binding.
Brodde OE; Leifert FJ; Krehl HJ
J Cardiovasc Pharmacol; 1982; 4(1):34-43. PubMed ID: 6176797
[TBL] [Abstract][Full Text] [Related]
9. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.
Chang RS; Lotti VJ
Life Sci; 1983 May; 32(22):2603-9. PubMed ID: 6134224
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic receptors in guinea-pig liver plasma membranes and thermal lability of [3H]dihydroalprenolol binding sites.
Kawai Y; Graham SM; Yoshioka H; Arinze IJ
Biochem Pharmacol; 1986 Dec; 35(24):4387-93. PubMed ID: 3024648
[TBL] [Abstract][Full Text] [Related]
11. Trachea relaxing effects and beta2-selectivity of SPFF, a newly developed bronchodilating agent, in guinea pigs and rabbits.
Gan LL; Wang MW; Cheng MS; Pan L
Biol Pharm Bull; 2003 Mar; 26(3):323-8. PubMed ID: 12612441
[TBL] [Abstract][Full Text] [Related]
12. Adrenergic receptor subtypes in rabbit iris-ciliary body membranes: classification by radioligand studies.
Mittag TW; Tormay A
Exp Eye Res; 1985 Feb; 40(2):239-49. PubMed ID: 2984032
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the apparent irreversible beta-adrenoceptor antagonist Ro 03-7894 with propranolol in cardiac ventricular muscle by pharmacological and radioligand binding techniques.
Rankin A; Broadley KJ
Biochem Pharmacol; 1982 Apr; 31(7):1325-32. PubMed ID: 6124256
[TBL] [Abstract][Full Text] [Related]
14. The (--)[3H]dihydroalprenolol binding to rat adipocyte membranes: an explanation of curvilinear Scatchard plots and implications for quantitation of beta-adrenergic sites.
Dax EM; Partilla JS; Gregerman RI
J Lipid Res; 1982 Sep; 23(7):1001-8. PubMed ID: 6292316
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
Riva MA; Creese I
Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
[TBL] [Abstract][Full Text] [Related]
16. [3H]dihydroalprenolol binding in the rat brainstem.
Stone EA; U'Prichard DC
Eur J Pharmacol; 1981 Oct; 75(2-3):159-61. PubMed ID: 6119217
[TBL] [Abstract][Full Text] [Related]
17. Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes.
Sharif NA; Xu SX; Crider JY; McLaughlin M; Davis TL
J Ocul Pharmacol Ther; 2001 Aug; 17(4):305-17. PubMed ID: 11572462
[TBL] [Abstract][Full Text] [Related]
18. Characterization of beta adrenoceptor subtypes in canine airway smooth muscle by radioligand binding and physiological responses.
Barnes PJ; Nadel JA; Skoogh BE; Roberts JM
J Pharmacol Exp Ther; 1983 May; 225(2):456-61. PubMed ID: 6132993
[TBL] [Abstract][Full Text] [Related]
19. R-enantiomer of timolol: a potential selective ocular antihypertensive agent.
Share NN; Lotti VJ; Gautheron P; Schmitt C; Gross DM; Hall RA; Stone CA
Graefes Arch Clin Exp Ophthalmol; 1984; 221(5):234-8. PubMed ID: 6092239
[TBL] [Abstract][Full Text] [Related]
20. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
